A groundbreaking platform that extends the reach of genetic treatments by combining unprecedented DNA optimisation with non-viral delivery.
We’re determined to provide the next generation of DNA-based therapies.
We have developed a purpose-built next generation platform to expand the reach of current gene therapies and provide hope to patients suffering from rare genetic diseases.
Platform for Next Generation DNA-based Therapies.
By combining our pioneering oDNA™ with exclusive innovative Non-Viral vector delivery, we are progressing re-dosable gene therapies with drug titration capabilities and targeted biodistribution, whatever the size of the gene involved.
Non-viral
DNA-based
medicine
Platform for Next Generation DNA-based Therapies.
By combining our pioneering oDNA™ with exclusive innovative Non-Viral vector delivery, we are progressing re-dosable gene therapies with drug titration capabilities and targeted biodistribution, whatever the size of the gene involved.
Enhancing DNA based therapies further ahead
01.
Redosing
Redosing ability to provide lifelong control of the disease
02.
Drug titration
Drug titration to deliver personalized treatment response
03.
Targeted delivery
Targeted biodistribution to organs and specific cell types
04.
No size limitation
No transgene size limitation to adress a wide range of diseases
05.
oDNA™ modulation
oDNA™ versatile modulation of transgene properties, beyond regulatory cassette
06.
Focused constructs
oDNA™ free of antibiotic resistance and any bacterial sequences